Christopher B Prentiss
CIK 1717583 · Chief Financial Officer · last filed 2026-04-24
Christopher B Prentiss is a Chief Financial Officer who has filed 24 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing shows the insider had shares withheld for taxes covering $33.6K of MNKD on Apr 24, 2026. Across all open-market trades the lifetime net is −$95.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.24M
2
24
-$95.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNKD | Chief Financial Officer | 338,924 | $3.66 | $1.24M | $0 | 7 | 2026-04-24 |
| Adamas Pharmaceuticals Inc (ADMS) Delisted | Chief Financial Officer | 0 | $8.22 | $0 | -$95.7K | 17 | 2021-11-24 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-24 | MNKD | Tax (F) | −12,267 | -$33.6K | EDGAR |
| 2026-03-25 | MNKD | Grant (A) | — | $0 | EDGAR |
| 2026-03-03 | MNKD | Grant (A) | +5,000 | $16.4K | EDGAR |
| 2025-07-17 | MNKD | Tax (F) | −11,540 | -$44.4K | EDGAR |
| 2025-05-15 | MNKD | Grant (A) | +119,000 | $0 | EDGAR |
| 2025-03-28 | MNKD | Grant (A) | +103,600 | $0 | EDGAR |
| 2024-05-17 | MNKD | Grant (A) | +232,600 | $0 | EDGAR |
| 2021-11-24 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Mixed | −145,017 | $0 | EDGAR |
| 2021-03-23 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Sell (S) | −2,422 | -$13.3K | EDGAR |
| 2021-03-03 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | +75,000 | $0 | EDGAR |